Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psilocybin and psychedelics in the treatment of chronic ... [Read]
Psychedelic Decriminalization Creating Market Opportunities
What was once a war on drugs has turned into a public push for the decriminalization and legalization of illegal drugs with potential therapeutic benefits. Legalization efforts began with marijuana in 2018, creating a booming ... [Read]
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Psychedelics are quietly being used in clinical settings on small numbers of patients, but they are moving quickly toward medical approval. The FDA recently approved large-scale human trials to determine whether MDMA and other psychedelics ... [Read]
Psychedelics Transition from Experimental Treatment to Major Pharmaceutical Industry
Psychedelic medicine is emerging as a breakthrough for mental health. After decades of research, drugs like psilocybin and ketamine are finally ready to move from the lab into the pharmacy and the therapist’s office. Several ... [Read]
Psychedelic-Derived Medicines Could Treat PTSD and ADHD | Companies are Positioning Themselves to Lead the Sector
After being stifled for decades by repressive drug laws and a stigma associating them with counterculture, research into psychedelic substances is finally being embraced by the government, corporations, and the medical community. In March, the ... [Read]